NCT06863844View on ClinicalTrials.gov

The Evaluation of Molecular Markers From PRedittivI DNA of Clinical Outcomes in Patients With UROthelial Tumor

RecruitingOBSERVATIONAL

Enrollment

210

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions

Urothelial Neoplasm

Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliero Universitaria Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER